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Abstract
Amniotic fluid contains precious therapeutic stem cells with ideal features such as they are 
broadly multipotent, genetically stable, and non-tumorigenic. One of the stem cells that 
is abundantly found in amniotic fluid is mesenchymal stem cells. Human amniotic fluid 
mesenchymal stem cells (hAFMSCs) had been successfully isolated from amniotic fluid 
obtained from second or third trimester amniocentesis. However, studies on hAFMSCs 
obtained during full-term delivery are still lacking. Furthermore, suitable culture media 
to propagate hAFMSCs for therapeutic purposes have not been fully established. Basal 
medium supplemented with fetal bovine serum is commonly used, and unfortunately, 
this condition has been associated with the risk of transmission of animal pathogens and 
xenogenic immune reaction. An efficient isolation and expansion method together with 
suitable culture conditions is essential in establishing a specific homogenous cell popula-
tion, such as full-term hAFMSCs, of clinical grade. In this chapter we briefly describe the 
feasibility of generating hAFMSCs from full-term amniotic fluid obtained during cesar-
ean section using serum-free medium as opposed to the conventional serum containing 
media. These findings would be very useful in utilizing stem cells for bench side applica-
tion from a source that is accessible and devoid of ethical and safety concerns.
Keywords: full-term amniotic fluid, cesarean, mesenchymal stem cells, postmitotic 
neurons, serum-free
1. Introduction
The robust development in regenerative medicine, especially the use of stem cells, has opened 
new treatment modalities in modern medicine. Substantially supported by the scientific 
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 evidence, stem cells promise “cures” to chronic diseases and are considered a valuable “sub-
stitute” to the conventional therapies. Thus, the dire need for “ready-to-use” or “off-the-shelf” 
sources of stem cells becomes very apparent because of increased demand for the stem cell 
therapy. Among the adult stem cells, mesenchymal stem cells (MSCs) have seized the world-
wide attention of many clinicians and scientists due to their unique characteristics. The regen-
erative capability of MSCs with an inherent immunosuppressive ability triggers an excellent 
outcome in repairing tissue injuries and restoring functions of many organs in the context of 
inflammatory milieu. However, similar to any other cell therapies, harvesting and acquiring 
an adequate number of cells for the therapeutical purposes still limit the wide use of MSCs. 
In line with this, the current study has explored the feasibility of exploiting a human delivery 
waste, namely, amniotic fluid to generate and propagate fetal-derived MSCs for the potential 
clinical applications.
Amniotic fluid appears at about 12 days after conception in between the amnion and chorion 
fetal membranes. Other than nutrients such as proteins, carbohydrates, lipids, phospholipids, 
and urea to support the growth of the fetus, the fluid also contains heterogenous population 
of cells that are sloughed off from the fetal skin and the digestive, respiratory, and urogenital 
tracts and from the amniotic membrane [1, 2]. The total number and proportion of viable cells 
may vary widely between samples from different pregnancies of the same gestation period 
[1]. Furthermore, the cell population also found to change with gestation corresponding to the 
developing fetus [3]. The types of cells found in human amniotic fluid are divided into three 
main groups—the epithelioid E-type cells, amniotic fluid-specific AF-type cells, and fibroblas-
tic F-type cells—which are classified according to the morphological, biochemical, and growth 
properties [4, 5]. E-type cells, which are round shaped and slow growing [6], are presumed 
to derive from the fetal skin and urine, while AF-type cells are from fetal membranes and 
trophoblast tissue (placenta) because these cells produce estrogen, human chorionic gonado-
tropin, and progesterone [1, 7]. F-type cells are considered to originate from mesenchymal 
tissue due to lack of any hormone production, and they do not express human leukocyte class 
II (HLA-DR) surface antigen [8].
Human amniotic fluid cells have been used to screen for fetal abnormalities for more than 
60 years, and only recently, their therapeutic value was discovered. A number of amniotic fluid-
derived cells have been identified and examined for their properties. Among all, amniotic epi-
thelial cells have been demonstrated to express glial and neuronal stem cell markers [9]. Midterm 
amniotic fluid stem cells (AFSCs) have been found to express c-kit as well as mesenchymal stem 
cell (MSC) surface markers [10]. These AFSCs were shown to have the ability to proliferate 
and maintain a normal karyotype for more than 250 population doublings [10]. Furthermore, 
several investigators demonstrated that AFSCs from both mid- and full-term amniotic fluid 
positively express pluripotent markers, differentiate into derivatives of all the three primary 
germ layers, and form embryoid bodies under the appropriate conditions; however, they are 
not tumorigenic [10, 11]. The human amniotic fluid mesenchymal stem cells (hAFMSCs) on the 
other hand are similar to AFSCs except the c-Kit, SSEA4 and OCT4 expressions are lesser, and 
their in vitro expansion only could last about 30–50 doublings [12]. Apart from these, amniotic 
fluid was also found to contain hematopoietic progenitor cells in the first trimester [3].
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The characteristics of amniotic fluid cells, particularly AFSCs and hAFMSCs, such as broadly 
multipotent, high proliferative potential, paracrine secretion activity, and non-tumorigenic in 
addition to devoid of ethical and safety issues will make them significant candidates in the 
field of regenerative medicine and drug screening.
2. Human full-term amniotic fluid-derived mesenchymal stem cells
The leftover amniocentesis samples of second-trimester amniotic fluid collected for the rou-
tine prenatal diagnosis are usually used for the isolation of amniotic fluid mesenchymal 
stem cells. At this gestational stage, it is impossible to collect a larger volume of amni-
otic fluid, and there are increased risks of uterine contamination and miscarriage [13]. 
Alternatively, stem cells could be isolated from amniotic fluid of full-term pregnancies, 
specifically during delivery. We attempted to generate hAFMSCs from full-term amniotic 
fluid obtained during cesarean section. The following sections describe their propagation 
using serum and serum-free media, phenotypic characterization, and in vitro differentia-
tion potential.
2.1. Culture techniques
Human amniotic fluid samples were obtained under an appropriate Ethical Committee 
approval and after signed informed consent from 14 women prior to cesarean procedure. The 
mean term pregnancy duration was 38 ± 1 weeks. About 10 ml of amniotic fluid was collected 
by puncturing the membranes after the uterine muscle was opened for the cesarean-section 
delivery. Cells were isolated from the human amniotic fluid samples not more than 4 hours from 
the time of collection. About 10 ml of human amniotic fluid was centrifuged for 10 minutes at 
1200 rpm, and 10,000 cells/cm2 tumorigenic were seeded in T25 flask and grown to confluence 
in (1) serum-free MesenCult™-XF (Stem Cell Technologies, Canada) complete medium (SFM) 
according to the manufacturer protocol, (2) low-glucose DMEM with GlutaMAX™ (Gibco 
BRL, Invitrogen, USA) supplemented with 15% fetal bovine serum (DMEM-FBS), and (3) low-
glucose DMEM with GlutaMAX™ supplemented with 15% human serum (DMEM-HS). The 
media were added with 1% penicillin/streptomycin (Gibco BRL, Invitrogen, USA). The cells 
were cultured in respective defined media at 37°C in 5% CO2 incubator (RS Biotech Galaxy, Irvine, UK). The initial media change was performed at day 5 and subsequently every 3–4 
days. Adherent cells achieved approximately 80% confluency around 15th day of the pri-
mary culture. The cells were harvested using 0.05% trypsin-EDTA (Gibco BRL, Invitrogen, 
USA) for 5 minutes at 37°C; cells were reseeded at 3000 cells/cm2 and subsequently expanded 
up to P7. Adherent cells with fibroblast-like spindle-shaped morphology (Figure 1) were 
observed at P0 in all respective culture media. However, only SFM medium grown cells 
were able to expand beyond P7; others, DMEM-FBS and DMEM-HS culture grown cells, 
were able to attach and proliferate till P3 and P1, respectively. Therefore, the downstream 
experiments could not be carried out at P3 and P7 for DMEM-HS and P7 for DMEM-FBS 
culture conditions, respectively.
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Morphologically, MSCs derived from human amniotic fluid resembled MSCs from other 
human tissues, especially the bone marrow. Adherence to the plastic surface and assuming 
spindle cell morphology are the criteria that minimally define MSCs along with stipulated 
immunophenotyping and the mesodermal differentiation. Despite the fact that all P0 cells 
from the respective media acquired an MSC-like morphology, the adherent cells from SFM 
media showed a much smaller, denser, and defined cell population as compared to other cul-
ture systems. These features reflect the nature of the expanding cells, where cells with rapid 
turnover appear small and with defined spindle morphology (Figure 1G and I) compared to 
the slowly growing cells with a broader and polygonal shape (Figure 1H). The morphologi-
cal observation of the SFM-expanded cells confers the high proliferative nature of the culture 
system (Figure 1G and I). Although, the content of SFM media is not fully disclosed, it might 
contain cocktail of growth factors that enhances cell proliferation, preserves the telomere 
length and prevents early cellular senescence.
2.2. Colony forming unit assay and population doubling time
The proliferations of hAFMSCs in these media were examined by colony forming unit-
fibroblast (CFU-F) assay and population doubling time (PDT). The ability to form CFU-F 
is one of the characteristics of MSCs [14]. PDT was carried out by seeding cells at P3 and 
P7 in respective T75 flasks with density of 10,000 cells/cm2 until cultures reach confluency. 
PDT was calculated using the following formula: PDT = CT/log (Nf/Ni), where CT = culture 
time, Nf = final number of cells, and Ni = initial number of cells at culture initiation. CFU-F 
assays were performed by plating 100 cells in the respective culturing media in 100 mm cell 
culture plate and incubated at 37°C in 5% CO2. On the 14th day, the cells were washed with 
Figure 1. Primary culture of full-term amniotic fluid-derived adherent cells in different culture media. (A, B, and C) 
Adherent cells were noticed from day 7 onward and took 2 weeks, 25 days, and 38 days to confluence in P0, respectively. 
(D and E) More spindle-shaped fibroblast-like cells were observed in P1. (F) Cells attached but failed to reach confluency. 
(G, H, and I) Higher percentage of homogenous population of spindle-shaped fibroblast-like cells was observed in 
DMEM-FBS and SFM at P3 and P7, respectively.
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Dulbecco’s phosphate buffered saline (DPBS) (pH 7.4) and stained using 10 ml 0.5% crystal 
violet (Sigma-Aldrich, USA) in methanol for 1 hour at room temperature. Plates were washed 
with DPBS twice, and colonies containing 50 or more cells were counted.
The hAFMSCs doubled in 36 hours and formed more colonies when cultured in SFM, which is 
defined for MSCs, while it took 6 days when cultured in DMEM-FBS (Table 1). The slow and 
poor growth of these cells in DMEM-FBS and DMEM-HS most likely because of the media 
was not supplemented with any additional growth factors. It could be possible that the lack 
of optimized serum batch selection for FBS and HS that support MSC colony formation and 
expansion rendered the observed non-conducive proliferation. The selection of serum batch 
for a particular cell type, especially stem cells, is crucial since the halted cellular expansion is 
often noticed due to senescence [15].
2.3. Immunophenotyping by flow cytometry analysis
Second-trimester hAFMSCs were reported to positively express CD44, CD73, CD90, CD105, 
and CD166 and lack of expression of CD14, CD19, CD34, CD45, and HLA-DR [16, 17]. In order 
to investigate the expression of MSC surface markers on the full-term hAFMSCs grown in dif-
ferent culture media, fluorescence-activated cell sorting analysis was carried out. Cultured 
cells were harvested and resuspended in DPBS supplemented with 1% FBS at a cell density 
of 1.0 × 106 cells/ml. Approximately 1 × 105 cells were incubated with 3 ul of labeled mouse 
antihuman monoclonal antibodies at 4°C for 30 minutes in dark and then washed with 1 ml 1× 
DPBS supplemented with 1% FBS. The following antibodies were used: CD44, CD73, CD90, 
CD105, CD166, CD14, CD19, CD34, CD45, and HLA-DR (BD Pharmingen, San Diego, CA). All 
analyses were normalized against negative control cells incubated with isotype specific to the 
respective antibodies. At least 10,000 events were acquired on Guava easyCyte™ flow cytom-
eter, and the results were analyzed using guavaSoft software (Millipore, USA). We found that 
more than 90% of the cells grown in SFM expressed all MSC-positive markers at P3 and P7 
(Figure 2). However, in DMEM-FBS, only about 50% of the P3 cultured cells expressed CD105 
and CD166. Lower percentage of cells expressing CD105 and CD166 was also reported by 
several researchers when second- and third-trimester hAFMSCs were cultured in different 
types of media supplemented with FBS [13, 16, 18].
Medium Passages PDT (hours) CFU-F (no. of colonies)
SFM 3 35.63 ± 0.16 82.11 ± 2.14
SFM 7 37.15 ± 1.22 75.89 ± 2.61
DMEM-FBS 3 146.1 ± 0.97 5.88 ± 1.53
The proliferation of the hAF cells is slower in DMEM-FBS than in SFM. Results are of three independent experiments.
Table 1. Population doubling time (PDT) and colony forming unit-fibroblast (CFU-F) analyses of full-term amniotic 
fluid-derived mesenchymal stem cells.
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2.4. Differentiation into mesodermal lineage
To study the multilineage capacity, hAFMSCs were subjected to differentiate under the 
conditions that promote osteogenesis, adipogenesis, and chondrogenesis (Figure 3). The 
Figure 3. Differentiation potential of SFM and DMEM-FBS cultured human full-term amniotic fluid mesenchymal stem 
cells into mesodermal lineages. Adherent cells were grown to confluency and subjected to the relevant induction media 
as per manufacturer’s protocol. Osteogenic, adipogenic, and chondrogenic differentiations were evidenced by stained 
calcium deposits, lipid droplets, and proteoglycan aggregates, respectively.
Figure 2. Human full-term amniotic fluid-derived adherent cells grown in SFM and DMEM-FBS showed typical 
mesenchymal stem cell molecular marker expression. Flow cytometry results showed that the adherent cells were 
absolutely positive for CD44, CD73, CD90, CD105, and CD166 while negative for CD14, CD19, CD34, CD45, and 
HLA-DR. Results are of three independent experiments.
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differentiations were performed using StemPro Adipogenesis, osteogenesis, and chondro-
genesis differentiation kits (Gibco, Invitrogen, USA) according to manufacturer’s protocol. 
Differentiation of MSCs into osteoblasts was demonstrated by staining the calcium deposition 
with Alizarin red. The adipogenic phenotype was determined by staining the cell monolayers 
with Oil Red O. Multiple intracellular lipid-filled droplets were observed which is consis-
tent with the phenotype of mature adipocytes. Chondrogenic differentiation was detected by 
staining extracellular proteoglycan aggrecan produced by the differentiated cells with alcian 
blue stain. Similar to the morphological and proliferation analyses, the mesodermal differen-
tiation of hAFMSCs grown in serum and serum-free media also varied based on the passage 
numbers and culture media. In agreement with others, the early passage (P3) of SFM-grown 
hAFMSCs differentiated at the greater extent as compared to the P7 hAFMSCs. Although the 
degree of differentiation was not quantitatively captured, the distribution and density of the 
relevant biochemical stainings have indicated the early passaged cells induced into matura-
tion with high magnitudes. When P3 cells from SFM and DMEM-FBS were compared, the 
degree of differentiation was lesser in the FBS-supplemented medium.
2.5. Spontaneous differentiation into postmitotic neurons
We also observed that the adherent cells derived from full-term amniotic fluid of few samples 
were growing in atypical manner compared to some of the propagated hAFMSCs when cul-
tured in SFM medium. Morphology of spindle-shaped fibroblast-like cells with neurite-like 
branching was noticed during expansion at P2 (Figure 4) as seen during standard in vitro 
neural differentiation process.
Preliminary tests were conducted to verify whether these cells had undergone neuronal differ-
entiation. The cells were confirmed positive for class III β-tubulin expression, a specific neuronal 
marker that can be detected during early neuronal differentiation and neurite outgrowth [19]; 
however, they were negative for microtubule-associated protein 2 (MAP-2), a marker for mature 
neurons. Immunocytochemistry (Figure 5) and flow cytometry (Figure 6) analyses revealed that 
more than 90% of the cell population expressed the class III β-tubulin protein as well as MSC 
markers (CD105, CD73, CD44, and GD2), however negative for MAP-2. These results indicate 
that the cells exhibited postmitotic neuronal cell identity while maintaining the MSC properties.
Figure 4. Neurite-like branching in primary culture of human full-term amniotic fluid-derived cells grown in SFM. (A) 
Heterogenous population of amniotic fluid cells was observed in P0. (B) Spindle-shaped fibroblast-like cells seen in P1. 
(C) Spindle-shaped fibroblast-like cells with neurite-like branching were noticed in P2.
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Figure 6. Expression of MSC surface and postmitotic neuron markers by flow cytometry of hAFMSCs grown in SFM. 
The adherent cells in P2 were positive for CD44, CD73, CD90, CD105, and GD2 while negative for CD14, CD19, CD45, 
and HLA-DR. About 91% cells exhibited positive class III β-tubulin expression; however, they were negative for MAP-2, 
suggesting the cells were postmitotic neurons and not matured neurons.
Figure 5. Expression of neuronal protein markers by immunocytochemistry. Passage 2 cells were stained with class III 
β-tubulin and MAP-2 to confirm the spontaneous neuronal differentiation. (A and D) Stained cells under phase contrast 
view. (C and F) Cells were counter stained with DAPI for nucleus staining. (B) Cells showing expression of class III β-tubulin 
indicating these cells were postmitotic neurons. (F) Cells did not express MAP-2 indicating the cells were not matured neurons.
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3. Discussion
The present study evaluated the human amniotic fluid-derived MSCs in terms of morphol-
ogy, expression of cell surface markers, and mesodermal differentiations in various culture 
conditions. The major limitation that blocks the progress of clinical trials relies on the ability 
of the cells to propagate in sufficient numbers for transplantation. In many cases, research-
ers can generate MSCs from various sources but failed to expand these cells beyond certain 
passages where it jeopardizes the subsequent exploration and transplantation studies. One 
should bear in mind that a successful use of MSCs from a respective source is only feasible 
when there is a culture system that allows expansion of particular cell type without compro-
mising its molecular properties. In this study, a commercially available SFM medium was 
tested along with other conventional media each supplemented with FBS or HS to escalate 
the expansion of hAFMSCs.
The standard practice for expansion of MSCs is mainly the use of FBS as it is the basic source 
of growth factors and low-molecular-weight bioactive compounds [20]. FBS is simple to 
use and supports undifferentiated MSC expansion; however, the drawbacks of using FBS-
containing medium in therapeutic application are lack of experimental reproducibility and 
may cause immunogenic reactions in patients [21]. In order to replace FBS, human serum 
has been used; nonetheless similar to FBS, there are issues such as variability between lots 
due to genetic diversity and lack of assurance that it will not transmit new and emerg-
ing infectious disease viruses [22]. Recently, for therapeutic purposes stem cells are being 
cultured in xeno-free or animal component-free media formulations to circumvent trans-
mission of xenogenic proteins and pathogens and to improve the outcome of cell trans-
plantation studies. Xeno-free media may contain material derived from the human plasma, 
while animal component-free media do not contain serum and other materials derived from 
animal or human sources.
In our work, commercial xeno-free, serum-free culture medium was used in conjunction with 
serum-free attachment substrate to support cell adhesion. The cells were also cultured in FBS 
and HS-containing media to evaluate the capacity of expansion and differentiation of hAFM-
SCs. The growth rate and morphology observations of our study were similar with other 
MSC studies carried out using serum-free and serum-supplemented media [21, 23, 24]. We 
found that the proliferation rate of the full-term amniotic fluid cells was higher in SFM, where 
the doubling time remained short and relatively consistent till seven passages compared to 
serum-containing media. Besides, we also noticed that the cells grown in SFM exhibited more 
elongated, spindle-shaped morphology and grow in distinct bundles of cells when continu-
ally expanded. In contrast, cells cultured in serum media displayed more flattened, fibroblast-
like morphology and even monolayer of cells. Human MSCs undergo replicative senescence 
with decreasing proliferation and changes in cell morphology, which were observed in early 
passage of cells cultured in both DMEM-FBS and DMEM-HS. This could be due to undefined 
factors in the serum; alternatively the rapid proliferation and longer life span of hAFMSCs in 
SFM are possibly contributed by the higher concentrations of growth factors present in this 
medium. In addition to robust proliferation rate, SFM also enhanced the clonogenic potential 
of the full-term hAFMSCs which is one of the properties of bona fide MSCs.
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Immunophenotyping is one of the main criteria for characterizing MSCs. International 
Society for Cellular Therapy (ISCT) proposed that multipotent human MSCs must express 
CD105, CD73, and CD90 and lack of expression of CD45, CD34, CD14 or CD11b, CD79α, 
CD19, and HLA-DR surface antigen [25]. Other positive markers currently included to 
define MSCs are CD166, CD44, CD29, and CD9 [26]. In our study, all the MSC-positive 
markers were highly expressed in full-term hAFMSCs expanded in SFM. The hAFMSCs 
cultured in DMEM-FBS moderately expressed CD105 and CD166. A similar expression 
pattern of CD105 and CD166 was also observed by other researchers during generation of 
MSCs derived from second- and third-trimester amniotic fluid using FBS-supplemented 
media [13, 16, 18]. CD105 plays a role in chondrogenic differentiation [27], while CD166 
is involved in neurite extension [28]. Probably due to lower expression of CD105, hAFM-
SCs grown in DMEM-FBS differentiated poorly into chondrocytes. hAFMSCs isolated in 
SFM were found to have higher trilineage mesoderm differentiation capacity. Martinez et 
al. [29] studied on neural ganglioside GD2 surface antigen on bone marrow MSCs after 
several researchers reported on neural antigen expression on MSCs. They found that GD2 
was consistently expressed at a high level on all freshly isolated or ex vivo expanded bone 
marrow MSCs but was not expressed in all other cells within the marrow. Likewise, Xu et 
al. [30] found that umbilical cord-derived MSCs were the only cells within umbilical cord 
that expressed this marker. These findings suggested that GD2 can be a unique marker for 
MSCs. It is also noteworthy that GD2 is one of the major gangliosides of the postmitotic neu-
rons [31] and was found to increase during neurite outgrowth [32]. When spindle-shaped 
cells with neurite-like outgrowth were noted in most of the SFM cultures, we investigated 
the MSC surface antigen expressions and included GD2 marker to confirm that the cells 
were indeed MSCs and have neurogenic potential. Class III β-tubulin and MAP-2 expres-
sion were also analyzed to examine whether the cells were postmitotic neurons or matured 
neurons. As suspected, the cells had differentiated spontaneously into postmitotic neurons. 
Interestingly, this morphology was not seen in DMEM-FBS cultures, probably due to lower 
expression of CD166 on these cells. Chase et al. [24] had reported that bone marrow MSCs 
grown in serum-free medium significantly enhanced the expression of the intermediate fila-
ment nestin when compared to cells expanded in serum-containing medium. MSCs at the 
earliest developmental stage were found to harbor stronger neurodifferentiation capacity 
than postnatal MSCs, acquiring characteristics of postmitotic neurons [33]. It was suggested 
that MSCs exhibit both stem cell and precursor functions allowing neuronal differentia-
tion through both mitotic stem cells and nonmitotic precursor pathways [34]. Many studies 
demonstrated that the morphological and molecular modifications of MSCs were probably 
due to stress response, rather than to a real differentiation into neuronal cells; however, 
some recent studies had demonstrated that MSC-derived cells not only showed morpho-
logical features of neurons, but that they also demonstrate functional properties of neurons 
[35]. There is evidence that MSCs from different sources may not have the same biological 
and genetic properties; probably for these reasons and neurotrophic cytokines that might 
be present in the microenvironment, the full-term hAFMSCs spontaneously differentiated 
into postmitotic neurons in our hands. These postmitotic neurons might turn into mature 
neurons upon further expansion. These findings suggest the possibility that the full-term 
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amniotic fluid-derived mesenchymal stem cells expanded in serum-free medium may serve 
as a source for stem cell-based regenerative medicine to a variety of therapeutic scenarios 
including treating the neurological disorders.
4. Conclusion
Our findings clearly demonstrated the feasibility of generating MSCs from full-term 
human amniotic fluid. SFM media were found to be most efficient in isolation and expan-
sion of full-term hAFMSCs. It is very interesting to note that the characteristics and 
behavior of the established hAFMSCs change under the influence of different culture 
media. Keeping these observations in mind, further work needs to be done to understand 
differentiation potential of full-term hAFMSCs before they can be applied in bedside 
settings.
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CFU-F Colony forming unit-fibroblast
DMEM-FBS Low-glucose DMEM with GlutaMAX™ supplemented with 
15% fetal bovine serum
DMEM-HS Low-glucose DMEM with GlutaMax™ supplemented with 15% 
human serum
DPBS Dulbeccos’s phosphate buffered saline
hAFMSC Human amniotic fluid mesenchymal stem cell
HLA-DR Human leukocyte antigen class II
MAP-2 Microtubule-associated protein 2
MSC Mesenchymal stem cell
PDT Population doubling time
SFM Serum-free MesenCult™-XF complete medium
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